Lv5
1080 积分 2022-07-16 加入
Establishing hepatic decompensation as a meaningful clinicaloutcome during systemic therapy for hepatocellular carcinoma
14天前
已完结
Establishing hepatic decompensation as a meaningful clinicaloutcome during systemic therapy for hepatocellular carcinoma
14天前
已完结
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study
21天前
已完结
Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial
21天前
已完结
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review
23天前
已完结
Spleen stiffness measurement for assessing the response to Β-blockers therapy for high-risk esophageal varices patients
24天前
已完结
Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices
24天前
已完结
Performance of spleen stiffness measurement in prediction of clinical significant portal hypertension: A meta-analysis
24天前
已关闭
Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma
25天前
已完结
Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma
25天前
已完结
皖公网安备34019202002308
